← FDA Drug Approvals (Drugs@FDA)

IBANDRONATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COBALT LABS INC · Approved 2011-03-15

Drug application

FDA Application #

ANDA079002

Application type

Abbreviated New Drug Application (Generic)

Brand name

IBANDRONATE SODIUM

Generic name

Ibandronate Sodium

Active ingredients

IBANDRONATE SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

COBALT LABS INC

First approval

2011-03-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown